-
EntrepreneurNutr Changing the way we milk
-
EntrepreneurDigital Asset Management A coin for the future of crypto Investing
-
EntrepreneurInvolio Verified Social Investing
-
InformationiCFO Information Booth How can we help?
-
EntrepreneurWelton Pharma Welton is utilizing Apisolex drug delivery technology to optimize pharmaceutical drug products
-
EntrepreneurPolyn Technology Breakthrough AI Solutions for Smart Sensors and Analog Front End
-
EntrepreneurCatchGPT Next Generation AI Detection
-
EntrepreneurOpus Genetics Envisioning a new future for patients with inherited retinal diseases
-
EntrepreneurGreenspace Labs An evidence-based approach to investigate and commercialize the medicinal potential of cannabinoid therapeutics.
Event iCFO Capital Global Virtual Conference - Palm Springs is over.
Join us next time to meet Artur Plonowski!
Join us next time to meet Artur Plonowski!
About Vasa Therapeutics
Vasa Therapeutics
Novel therapeutics for unmet medical needs in cardiovascular medicine
Available from
12:00 PM
-
4:00 PM
(US/Pacific)
+1 408-410-1159
Vasa Therapeutics is addressing significant unmet medical needs in cardiovascular and metabolic medicine: heart failure, obesity, sarcopenia, peripheral artery disease, and life-threatening arrhythmias. The company has developed an attractive pipeline of projects with validated mechanisms of action and strong biomarker support. The company is led by a highly experienced management team with a track record of drug development and strategic partnerships. In addition to the current series seed, the company is pursuing non-dilutive funding opportunities through grants ($2.3M awarded to date) and potential strategic partnerships at pre-clinical stage.